PE20090910A1 - Composicion topica - Google Patents
Composicion topicaInfo
- Publication number
- PE20090910A1 PE20090910A1 PE2008001823A PE2008001823A PE20090910A1 PE 20090910 A1 PE20090910 A1 PE 20090910A1 PE 2008001823 A PE2008001823 A PE 2008001823A PE 2008001823 A PE2008001823 A PE 2008001823A PE 20090910 A1 PE20090910 A1 PE 20090910A1
- Authority
- PE
- Peru
- Prior art keywords
- composition
- emulsion
- alcohol
- topical composition
- oleilic
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000000699 topical effect Effects 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical class CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 abstract 2
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 1
- 229960001259 diclofenac Drugs 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000002191 fatty alcohols Chemical class 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002736 nonionic surfactant Substances 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA TOPICA QUE SE PRESENTA EN FORMA DE UNA EMULSION-GEL OPACA QUE CONTIENE: A) 1,2% A 4% P/P DE LA SAL DE DIETILAMONIO DE DICLOFENACO; B) 0,5% A 2% P/P DE UN ALCOHOL GRASO (C10-C18) TAL COMO ALCOHOL OLEILICO; C) 40% P/P DE AGUA; D) 10% A 30% P/P DE UN ALCANOL(C2-C4) TAL COMO ETANOL E ISOPROPANOL; E) 3% A 15% P/P DE UN DISOLVENTE DE GLICOL TAL COMO 1,2-PROPANODIOL; F) 0,5% A 5% P/P DE UN AGENTE DE GELIFICACION TAL COMO CARBOMEROS; G) 2% A 8% P/P DE UN LIPIDO LIQUIDO QUE FORMA LA FASE ACEITOSA DE LA EMULSION TAL COMO GLICERIDOS, ESTERES DE ACIDOS GRASOS, ENTRE OTROS; H) 1% A 3% P/P DE UN TENSIOACTIVO NO IONICO; E I) 0,5% A 2% DE DIETILAMINA PARA AJUSTAR EL PH DE LA COMPOSICION DE 6,5 A 8,5. DICHA COMPOSICION TIENE UNA ALTA PERMEACION EN LA PIEL PERO UNA ABSORCION SISTEMICA MUY BAJA, SIENDO UTIL EN EL TRATAMIENTO DE ARTROSIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07119599A EP2055298A1 (en) | 2007-10-30 | 2007-10-30 | Topical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090910A1 true PE20090910A1 (es) | 2009-07-08 |
Family
ID=39156258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001823A PE20090910A1 (es) | 2007-10-30 | 2008-10-24 | Composicion topica |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20100286268A1 (es) |
| EP (2) | EP2055298A1 (es) |
| JP (1) | JP5616228B2 (es) |
| KR (1) | KR101531729B1 (es) |
| CN (2) | CN101820860A (es) |
| AU (1) | AU2008317737B2 (es) |
| BR (1) | BRPI0819152B8 (es) |
| CA (1) | CA2701703A1 (es) |
| ES (1) | ES2633919T3 (es) |
| IL (1) | IL204658A (es) |
| MX (1) | MX2010004613A (es) |
| NZ (1) | NZ584179A (es) |
| PE (1) | PE20090910A1 (es) |
| PL (1) | PL2214642T3 (es) |
| PT (1) | PT2214642T (es) |
| RU (1) | RU2497516C2 (es) |
| TW (1) | TWI527597B (es) |
| WO (1) | WO2009056522A1 (es) |
| ZA (1) | ZA201002072B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG174612A1 (en) * | 2009-04-08 | 2011-11-28 | Cadila Healthcare Ltd | Stable pharmaceutical compositions of diclofenac |
| US20130197092A1 (en) * | 2009-12-07 | 2013-08-01 | Ketan R. Patel | Novel Non-Aqueous Topical Solution of Diclofenac and Process for Preparing the Same |
| GB0921686D0 (en) * | 2009-12-11 | 2010-01-27 | Reckitt Benckiser Healthcare I | Topical formulation |
| JP6131523B2 (ja) * | 2011-03-25 | 2017-05-24 | 大正製薬株式会社 | ロキソプロフェン含有外用剤 |
| CN102525886B (zh) * | 2012-01-13 | 2013-03-13 | 湖北科益药业股份有限公司 | 双氯芬酸二乙胺乳胶剂及其制备方法 |
| ITMI20121205A1 (it) | 2012-07-11 | 2014-01-12 | Glycores 2000 Srl | Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione |
| BR112015000329A2 (pt) * | 2012-07-12 | 2017-06-27 | Ferring Bv | formulações de diclofenac |
| FR3001544B1 (fr) | 2013-01-31 | 2015-02-27 | Commissariat Energie Atomique | Procede de reglage de la position relative d'un analyte par rapport a un faisceau lumineux |
| JP6449554B2 (ja) * | 2014-03-30 | 2019-01-09 | 小林製薬株式会社 | 外用医薬組成物 |
| EP3191082A1 (en) | 2014-09-10 | 2017-07-19 | Novartis Consumer Health S.A. | Topical diclofenac sodium compositions |
| EP3592336A1 (en) * | 2017-03-07 | 2020-01-15 | Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. | Topical delivery systems for active compounds |
| BE1026073B1 (nl) * | 2018-03-05 | 2019-10-07 | Purna Pharmaceuticals Nv | Verbeterde werkwijze voor het maken van een farmaceutische emulsie |
| JPWO2020004599A1 (ja) * | 2018-06-29 | 2021-05-13 | 株式会社日本触媒 | ゲルインオイル型エマルション及び経皮吸収剤 |
| US20220378729A1 (en) * | 2019-11-06 | 2022-12-01 | Smartech Topical, Inc. | Topical formulations of cyclooxygenase inhibitors and their use |
| CN112263542B (zh) * | 2020-10-19 | 2023-09-01 | 澳美制药厂有限公司 | 地奈德纳米乳凝胶组合物及其制备方法 |
| WO2023180792A1 (en) | 2022-03-25 | 2023-09-28 | Glycores 2000 Srl | Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT370721B (de) | 1981-02-24 | 1983-04-25 | Ciba Geigy Ag | Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der |
| CH655656B (es) * | 1982-10-07 | 1986-05-15 | ||
| IL101387A (en) * | 1992-03-26 | 1999-11-30 | Pharmos Ltd | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
| US5795916A (en) * | 1994-08-09 | 1998-08-18 | Tsumura & Co. | Composition of external preparation |
| JP2548686B2 (ja) * | 1995-04-06 | 1996-10-30 | エスエス製薬株式会社 | 外用薬剤組成物 |
| JP3802105B2 (ja) | 1995-06-27 | 2006-07-26 | 久光メディカル株式会社 | ジクロフェナクナトリウム含有乳化外用剤 |
| WO1997028794A1 (fr) * | 1996-02-07 | 1997-08-14 | Tsumura & Co. | Solution aqueuse transparente de diclofenac sodique, compositions medicinales, et utilisations |
| AU2953497A (en) | 1996-05-13 | 1997-12-05 | Novartis Consumer Health S.A. | Topical composition |
| JP4275751B2 (ja) * | 1996-12-27 | 2009-06-10 | 久光製薬株式会社 | 外用組成物 |
| CZ290752B6 (cs) | 1997-03-21 | 2002-10-16 | Chemopharma-Trade, S.R.O. | Emulgelový přípravek s protizánětlivým, analgetickým nebo protirevmatickým účinkem a způsob jeho výroby |
| KR19990026792A (ko) * | 1997-09-26 | 1999-04-15 | 김윤 | 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제 |
| US6635674B1 (en) * | 1998-11-06 | 2003-10-21 | Bristol-Myers Squibb Co. | Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| WO2000051575A1 (en) * | 1999-03-01 | 2000-09-08 | Amarin Technologies S.A. | Transdermal device comprising non-steroidal anti-inflammatory drugs incorporated in acrylic adhesive polymer matrix |
| US6235314B1 (en) | 2000-08-08 | 2001-05-22 | Sarfaraz K. Niazi | Analgesic, anti-inflammatory and skeletal muscle relaxant compositions |
| TWI290464B (en) * | 2000-09-01 | 2007-12-01 | Novartis Consumer Health Sa | Treatment of burns |
| GB0108082D0 (en) | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
| AR041021A1 (es) | 2002-08-22 | 2005-04-27 | Novartis Consumer Health Sa | Composicion topica |
| AR036755A1 (es) * | 2002-10-07 | 2004-09-29 | Thalas Group Inc | Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel |
| US7132452B2 (en) * | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
| JP4866546B2 (ja) * | 2004-12-10 | 2012-02-01 | 久光製薬株式会社 | ジクロフェナク含有乳剤性軟膏剤 |
-
2007
- 2007-10-30 EP EP07119599A patent/EP2055298A1/en not_active Withdrawn
-
2008
- 2008-10-24 PE PE2008001823A patent/PE20090910A1/es not_active Application Discontinuation
- 2008-10-27 MX MX2010004613A patent/MX2010004613A/es active IP Right Grant
- 2008-10-27 CA CA2701703A patent/CA2701703A1/en not_active Abandoned
- 2008-10-27 NZ NZ584179A patent/NZ584179A/en unknown
- 2008-10-27 CN CN200880110569A patent/CN101820860A/zh active Pending
- 2008-10-27 EP EP08844931.9A patent/EP2214642B1/en not_active Revoked
- 2008-10-27 US US12/740,041 patent/US20100286268A1/en not_active Abandoned
- 2008-10-27 BR BRPI0819152A patent/BRPI0819152B8/pt active IP Right Grant
- 2008-10-27 PL PL08844931T patent/PL2214642T3/pl unknown
- 2008-10-27 JP JP2010531508A patent/JP5616228B2/ja active Active
- 2008-10-27 AU AU2008317737A patent/AU2008317737B2/en active Active
- 2008-10-27 PT PT88449319T patent/PT2214642T/pt unknown
- 2008-10-27 CN CN201410346367.9A patent/CN104095806A/zh active Pending
- 2008-10-27 KR KR1020107009430A patent/KR101531729B1/ko not_active IP Right Cessation
- 2008-10-27 ES ES08844931.9T patent/ES2633919T3/es active Active
- 2008-10-27 RU RU2010121989/15A patent/RU2497516C2/ru active
- 2008-10-27 WO PCT/EP2008/064533 patent/WO2009056522A1/en active Application Filing
- 2008-10-28 TW TW097141313A patent/TWI527597B/zh active
-
2010
- 2010-03-22 IL IL204658A patent/IL204658A/en not_active IP Right Cessation
- 2010-03-24 ZA ZA2010/02072A patent/ZA201002072B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100083799A (ko) | 2010-07-22 |
| RU2010121989A (ru) | 2011-12-10 |
| AU2008317737A1 (en) | 2009-05-07 |
| IL204658A (en) | 2015-10-29 |
| EP2214642A1 (en) | 2010-08-11 |
| US20100286268A1 (en) | 2010-11-11 |
| EP2055298A1 (en) | 2009-05-06 |
| WO2009056522A1 (en) | 2009-05-07 |
| BRPI0819152B1 (pt) | 2019-02-05 |
| PL2214642T3 (pl) | 2017-10-31 |
| BRPI0819152B8 (pt) | 2021-05-25 |
| AU2008317737B2 (en) | 2014-06-05 |
| JP5616228B2 (ja) | 2014-10-29 |
| ZA201002072B (en) | 2011-05-25 |
| EP2214642B1 (en) | 2017-05-03 |
| NZ584179A (en) | 2012-05-25 |
| JP2011500863A (ja) | 2011-01-06 |
| CA2701703A1 (en) | 2009-05-07 |
| KR101531729B1 (ko) | 2015-06-25 |
| TW200934530A (en) | 2009-08-16 |
| IL204658A0 (en) | 2010-11-30 |
| ES2633919T3 (es) | 2017-09-26 |
| PT2214642T (pt) | 2017-07-27 |
| RU2497516C2 (ru) | 2013-11-10 |
| CN101820860A (zh) | 2010-09-01 |
| MX2010004613A (es) | 2010-05-20 |
| CN104095806A (zh) | 2014-10-15 |
| TWI527597B (zh) | 2016-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090910A1 (es) | Composicion topica | |
| ES2539861T3 (es) | Formulaciones en emulsión de clevidipina que contienen agentes antimicrobianos | |
| ES2524320T3 (es) | Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo | |
| CL2013003163A1 (es) | Composición transdermica de ibuprofeno, util en el tratamiento del dolor o la inflamacion. | |
| PE20141539A1 (es) | Una nueva composicion terapeutica que contiene apomorfina como principio activo | |
| JP2015527386A5 (es) | ||
| CL2011001225A1 (es) | Formulacion farmaceutica en solucion acuosa que comprende desde 1% hasta 5% (p/v) de una sal de diclofenaco, desde 3% hasta 30% (p/v) de al menos un polioxialquilen ester de hidroxido de acido graso y un co-solvente seleccionado de etanol, propanol, glicerol, propilenglicol entre otros. | |
| PE20130216A1 (es) | Formulacion topica para un inhibidor de jak | |
| CU23980B1 (es) | Formulación liposomal y proceso para la preparación del mismo | |
| AR081542A1 (es) | Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno | |
| CL2011002053A1 (es) | Composicion farmaceutica de espuma en aerosol en emulsion de aceite en agua que comprende un agente farmaceuticamente activo, agua, aceite, disolvente organico, componente tensoactivo, y propulsor; procedimiento de preparacion; uso para tratar enfermedades, o afecciones de la piel. | |
| BR112016018673A2 (pt) | Composições de sistemas de distribuição de nanoemulsão | |
| AR062653A1 (es) | Composiciones topicas | |
| CO5590905A2 (es) | Composiciones farmaceuticas que comprenden compuestos activos de vitamina d | |
| WO2015071298A3 (en) | Foaming composition comprising at least one glycinate type surfactant | |
| PE20070377A1 (es) | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol | |
| PE20110449A1 (es) | Emulsiones modificadas de liberacion de medicina para aplicacion a la piel o la mucosa vaginal | |
| AR060847A1 (es) | Formulacion a base de calendula, aloe y centella. | |
| CO6531482A2 (es) | Composiciones limpiadoras liquidas viscosas que comprenden ácidos grasos sulfonados, esteres o sales de los mismos y betamínas o sultaínas | |
| AR044050A1 (es) | Utilizacion de ivermectina para el tratamiento de desordenes dermatologicos | |
| BR112015010504A2 (pt) | uso de inibidores de molécula pequena de malt1, método de identificação de um modulador de molécula pequena de malt1, e composição farmacêutica | |
| PE20110642A1 (es) | Formulaciones antifungicas topicas a base de terbinafina y compuestos similares a terbinafina y metodos de uso | |
| AR092685A1 (es) | Formulaciones espumantes de cuidado de la piel | |
| AR041021A1 (es) | Composicion topica | |
| AR093297A1 (es) | Formulacion liquida que comprende un compuesto neutralizante de gm-csf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |